Can J Anesth/J Can Anesth (2017) 64:928–934 DOI 10.1007/s12630-017-0914-0 REPORTS O F O RIGINAL I NVES TIGATIONS Low-dose subcutaneous ketamine for postoperative pain management in Rwanda: a dose-ﬁnding study ´ ´ ` Ketamine sous-cutaneea faible dose pour la prise en charge de la ´ ´ ´ douleur postoperatoire au Rwanda : une etude de determination de dose . . Jon Tuchscherer, MD William P. McKay, MD Theogene Twagirumugabe, MD Received: 22 December 2016 / Revised: 30 March 2017 / Accepted: 2 April 2017 / Published online: 19 June 2017 Canadian Anesthesiologists’ Society 2017 Abstract (1.1), respectively]. This rate of improvement suggests Purpose Good pain control is not a normal part of possible pain relief through use of ketamine. The mean surgical care in sub-Saharan Africa due to lack of (SD) ketamine dose that appeared efﬁcacious in pain -1 resources. The primary objective of this study was to reduction was 0.90 (0.23) mgkg . There were no serious determine an efﬁcacious dose of subcutaneous ketamine for side effects. postoperative pain for use in a future randomized Conclusion Adding subcutaneous ketamine to standard controlled trial. analgesic measures resulted in decreases in postoperative Methods Following research ethics board and local pain scores
Canadian Journal of Anesthesia/Journal canadien d'anesthésie – Springer Journals
Published: Jun 19, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera